Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Proposed Acquisition Paves Path for 707 Cayman to Enter Pharmaceutical Market

707 Cayman Holdings Limited is set to significantly expand its operations by entering the pharmaceutical sector through the proposed acquisition of Crucial Innovation Inc. The transaction is backed by $10.25 million in financing, primarily led by GeoNova Holdings. This financing is intended to facilitate …

Vinay Lochav | 25 August 2026

Endovia Health Sciences Secures FDA INAD File No. 14145 for CannEpil®

This achievement initiates the formal regulatory process for CannEpil® as an investigational veterinary pharmaceutical aimed at managing cancer-related pain in companion animals. This milestone underscores the company's commitment to addressing a critical need in veterinary medicine, given the absence of FDA-approved therapies specifically for …

Vinay Lochav | 25 August 2026

Boeing Secures $131 Billion F-15 Fighter Jet Contract, Boosting Defense Outlook

The financial implications are substantial, as this contract enhances Boeing's market position within the defense sector, providing a steady stream of income over the coming years. This development signals renewed confidence in the U.S. defense industry, with the potential to elevate stock prices across …

Vinay Lochav | 25 August 2026

Merck (NYSE: MRK) Shares Jump 12.6% to Record $152.20 on Melanoma Trial Success

Merck & Co. Inc. (NYSE: MRK), which boasts a marketCapitalizationof approximately $371.7 billion and reported revenue of $65.01 billion, recently experienced a significant surge in its stock price. Shares climbed 12.6% to reach a record high of $152.20 on August 19, buoyed by the …

Vinay Lochav | 25 August 2026

Caterpillar Stock Surges 96% as Backlog Hits Record $37.5B

Caterpillar's stock has seen a dramatic 96% increase between August 2025 and August 2026, signifying a market shift in response to strong underlying order volumes. Revenue had shown a decline of 4.9% before this surge took place, prompting skepticism among investors regarding the company’s …

Vinay Lochav | 25 August 2026

Septerna (NASDAQ: SEPN) Appoints Rajiv Patni, M.D. Chief Medical Officer

This strategic move is intended to bolster the company's leadership team as it progresses in its mission to develop innovative oral medications that target G protein-coupled receptors (GPCRs). Patni's extensive background in clinical development and regulatory affairs positions him to significantly influence the success …

Vinay Lochav | 25 August 2026

Generate Biomedicines Set to Release 25 Million Shares Tomorrow

Generate Biomedicines Inc has seen its stock price rise by over 20% as the expiration of its post-IPO lock-up period approaches. The surge in stock price indicates that investors are positioning themselves ahead of increased supply in the market. Market reactions of this nature …

Vinay Lochav | 25 August 2026

Oppenheimer Upgrades Capricor, Boosting Investor Confidence

Capricor Therapeutics stock has surged significantly following an upgrade by Oppenheimer, as investors reacted positively to recent developments that could affect the company's regulatory standing. This upward movement in stock price signifies a renewed optimism in Capricor’s potential, driven by expectations of forthcoming advancements …

Vinay Lochav | 25 August 2026

Zymeworks (NASDAQ: ZYME) Eligible for Up to $1.3B Post FDA Approval

The recent FDA approval marks a significant advancement, permitting the use of Ziihera in conjunction with Tevimbra® (tislelizumab-jsgr) and standard chemotherapy for adult patients afflicted with HER2-positive gastroesophageal adenocarcinoma (GEA). This multi-faceted treatment approach is designed to tackle a particularly aggressive form of cancer, …

Vinay Lochav | 25 August 2026
Support

Hi! How can we help you today?

Loading…